Free Trial

Jacobio Pharmaceuticals Group (JBPHF) Short Interest Ratio & Short Volume

$0.30 0.00 (0.00%)
(As of 11/20/2024 ET)

Jacobio Pharmaceuticals Group Short Interest Data

Jacobio Pharmaceuticals Group (JBPHF) has a short interest of 768,900 shares. This marks a -38.12% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.0, indicating that it would take 0.0 days of the average trading volume of 0 shares to cover all short positions.

Current Short Interest
768,900 shares
Previous Short Interest
1,242,600 shares
Change Vs. Previous Month
-38.12%
Dollar Volume Sold Short
$226,825.50
Short Interest Ratio
0.0 Days to Cover
Last Record Date
October 31, 2024
Today's Trading Volume
0 shares
Average Trading Volume
0 shares
Today's Volume Vs. Average
NaN
Short Selling Jacobio Pharmaceuticals Group?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Jacobio Pharmaceuticals Group and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

JBPHF Short Interest Over Time

JBPHF Days to Cover Over Time

JBPHF Percentage of Float Shorted Over Time

Jacobio Pharmaceuticals Group Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
10/31/2024768,900 shares $226,825.50 -38.1%N/A0 $0.30
10/15/20241,242,600 shares $366,567.00 -9.2%N/A0 $0.30
9/30/20241,368,900 shares $403,825.50 -4.6%N/A0 $0.30
9/15/20241,435,500 shares $423,472.50 -13.8%N/A0 $0.30
8/31/20241,665,000 shares $491,175.00 No ChangeN/A0 $0.30
8/15/20241,665,000 shares $491,175.00 No ChangeN/A0 $0.30
7/31/20241,665,000 shares $491,175.00 No ChangeN/A0 $0.30
7/15/20241,665,000 shares $491,175.00 No ChangeN/A0 $0.30
6/30/20241,665,000 shares $491,175.00 No ChangeN/A0 $0.30
6/15/20241,665,000 shares $491,175.00 No ChangeN/A0 $0.30
5/31/20241,665,000 shares $491,175.00 No ChangeN/A0 $0.30
5/15/20241,665,000 shares $491,175.00 No ChangeN/A0 $0.30
4/30/20241,665,000 shares $491,175.00 No ChangeN/A0 $0.30
4/15/20241,665,000 shares $491,175.00 No ChangeN/A0 $0.30
3/31/20241,665,000 shares $491,175.00 No ChangeN/A0 $0.30
3/15/20241,665,000 shares $491,175.00 -0.3%N/A0 $0.30
2/29/20241,670,000 shares $492,650.00 +0.3%N/A1518.2 $0.30
2/15/20241,665,000 shares $607,059.00 No ChangeN/A0 $0.36
1/15/20241,665,000 shares $607,059.00 No ChangeN/A0 $0.36
12/31/20231,665,000 shares $607,059.00 No ChangeN/A0 $0.36
12/15/20231,665,000 shares $607,059.00 No ChangeN/A0 $0.36
11/30/20231,665,000 shares $607,059.00 No ChangeN/A0 $0.36
11/15/20231,665,000 shares $0.00 No ChangeN/A0 $0.00
10/31/20231,665,000 shares $607,059.00 -0.3%N/A0 $0.36
10/15/20231,670,100 shares $608,918.46 +0.3%N/A0 $0.36
9/30/20231,665,000 shares $607,059.00 No ChangeN/A16650 $0.36
9/15/20231,665,000 shares $805,527.00 -0.3%N/A0 $0.48
8/31/20231,670,400 shares $808,139.52 +0.1%N/A0 $0.48
8/15/20231,668,600 shares $807,268.68 +25.1%N/A0 $0.48
7/31/20231,333,800 shares $645,292.44 +735.7%N/A0 $0.48
7/15/2023159,600 shares $77,214.48 +2,318.2%N/A798 $0.48
6/30/20236,600 shares $0.00 +100.0%N/A0 $0.00

JBPHF Short Interest - Frequently Asked Questions

What is Jacobio Pharmaceuticals Group's current short interest?

Short interest is the volume of Jacobio Pharmaceuticals Group shares that have been sold short but have not yet been covered or closed out. As of October 31st, traders have sold 768,900 shares of JBPHF short. Learn More on Jacobio Pharmaceuticals Group's current short interest.

Is Jacobio Pharmaceuticals Group's short interest increasing or decreasing?

Jacobio Pharmaceuticals Group saw a drop in short interest in the month of October. As of October 31st, there was short interest totaling 768,900 shares, a drop of 38.1% from the previous total of 1,242,600 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.08 billion), AppLovin Co. ($3.18 billion), Paychex, Inc. ($2.64 billion), Nu Holdings Ltd. ($2.54 billion), International Paper ($2.46 billion), Cencora, Inc. ($2.27 billion), Moderna, Inc. ($1.87 billion), SoFi Technologies, Inc. ($1.81 billion), Lululemon Athletica Inc. ($1.75 billion), and Onsemi ($1.71 billion). View all of the most shorted stocks.

What does it mean to sell short Jacobio Pharmaceuticals Group stock?

Short selling JBPHF is an investing strategy that aims to generate trading profit from Jacobio Pharmaceuticals Group as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Jacobio Pharmaceuticals Group?

A short squeeze for Jacobio Pharmaceuticals Group occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of JBPHF, which in turn drives the price of the stock up even further.

How often is Jacobio Pharmaceuticals Group's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including JBPHF, twice per month. The most recent reporting period available is October, 31 2024.




This page (OTCMKTS:JBPHF) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners